Laboratory Services
Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum
Print this pageUpdated Test Information:
| Test Description |
Bullous Pemphigoid, BP180 and BP230, IgG Antibodies, Serum
|
|
|---|---|---|
| Synonym(s) |
BP180, BP230, Bullous Pemphigoid |
|
| Test ID |
BPAB
|
|
| General Information |
Initial screening test in the diagnosis of bullous pemphigoid and its variants Complementing the standard serum test of indirect immunofluorescence utilizing primate esophagus substrate and primate salt-split skin substrate (CIFS / Cutaneous Immunofluorescence Antibodies [IgG], Serum) |
|
| Container Type |
Red Top |
|
| Specimen Type |
Serum |
|
| Specimen Requirements |
1 mL |
|
| Specimen Collection / Processing Instructions |
Centrifuge and aliquot serum into plastic vial |
|
| Minimum Sample Volume |
0.5 mL |
|
| Stability |
Refrigerated (preferred) 14 days |
|
| Methodology |
Enzyme-Linked Immunosorbent Assay (ELISA) |
|
| Estimated TAT |
1 to 5 days |
|
| Testing Schedule |
Varies |
|
| Retention |
30 days |
|
| CPT Code(s) |
83516 x 2 |
|
| Reference Range |
BULLOUS PEMPHIGOID 180: <20 RU/mL (negative) > or =20 RU/mL (positive)
BULLOUS PEMPHIGOID 230: <20 RU/mL (negative) > or =20 RU/mL (positive) |
|
| Performing Lab |
Mayo |
|
| LOINC Code(s) |
92671-7 |
